Novo Nordisk, Sanofi, and Eli Lilly Lead in the $12 Billion U.S. Diabetes Market

News   Jul 15, 2013

 
Novo Nordisk, Sanofi, and Eli Lilly Lead in the $12 Billion U.S. Diabetes Market
 
 
 

RELATED ARTICLES

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Tweak to Technique Could Bolster Disease Detection

News

A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.

READ MORE

Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication

News

Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE